Brussels, 30/07/2014 (Agence Europe) - On Tuesday 29 July, the European Society for Medical Oncology (ESMO) raised its concerns over the consequences for its field of the current reform of the European rules on data protection. ESMO fears that the General Data Protection Regulation could make cancer research impossible due to the safeguards imposed for data handling. More specifically, the association takes issue with the notion of “explicit and specific patient consent”. “Hope for...